Business / Finance

RSS

Auxilium Licenses Stendra From Vivus For Up To $300M

...

11 Oct 2013

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

...

11 Oct 2013

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

...

11 Oct 2013

Yale Launches Collaboration With ARO, CRO Partners

...

11 Oct 2013

Yale Launches Collaboration With ARO, CRO Partners

...

11 Oct 2013

Auxilium Licenses Stendra From Vivus For Up To $300M

...

11 Oct 2013

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

...

11 Oct 2013

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

...

11 Oct 2013

DePuy Synthes Spine expands collaboration with Brainlab

DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.

11 Oct 2013

ImmunoGen signs new license agreement with Novartis

ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that Novartis has licensed the exclusive right to use the Company's ADC technology to develop anticancer therapeutics to an undisclosed target.

11 Oct 2013

Teva Cutting 5,000 Jobs In Global Restructuring

...

10 Oct 2013

J&J Innovation, Janssen, And Joslin Diabetes To Pump Up Exercise-Related Targets

...

10 Oct 2013

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

...

10 Oct 2013

Welichem Biotech announces results of substantial issuer bid

Welichem Biotech Inc. announces today the results of its substantial issuer bid, pursuant to which the Company offered to purchase for cancellation up to 23,529,411 of its issued and outstanding common shares ("Shares") at a purchase price of $0.85 per Share for an aggregate purchase price of up to $20 million (the "Offer"). The offer expired at 5:00 p.m. (Toronto time) on October 9, 2013.

10 Oct 2013

KFx Medical Corporation receives $29M in patent infringement case against Arthrex Inc.

KFx Medical Corporation announced that a jury in the United States District Court for the Southern District of California awarded KFx $29 million in its patent infringement case against Arthrex.

10 Oct 2013

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

10 Oct 2013